FibroGen’s anemia drug fails to meet main goal in late-stage trial

The drug was being studied for the treatment of anemia in patients with a type of bone marrow cancer who are dependent on transfusion. The primary goal of the study had been transfusion independence …

Spread the love

Leave a Reply

Your email address will not be published. Required fields are marked *